|
Sponsored by
The Pharmaceutical
Compliance Forum
|
SIXTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
Transformational Learning - Effective Knowledge Exchange
JW Marriott Hotel
Washington, DC
November 7 - 9, 2005
|
|
|
SEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
November, 8 - 10, 2006
Washington, DC
|
|
NOW AVAILABLE!
|
Purchase a CD-ROM which includes video of speakers with synced powerpoint presentations.
The Sixth Pharma Congress on CD-ROM
View the Sixth Annual Pharmaceutical Regulatory and Compliance Congress plenary sessions video with synchronized PowerPoint slides and concurrent sessions audio on a CD-ROM from your computer. Instantly navigate to the presenter and the exact content you are after.
Ensure that your team's knowledge is current.
Click here for more details
and to order your copy today!
|
|
AN INVITATION TO ATTEND THAT PHARMA CONGRESS FROM THE PCF PHARMA CONGRESS PLANNING COMMITTEE
|
|
The special Pharmaceutical Compliance Forum Pharma Congress planning committee invites individuals interested in the promotion of effective regulatory compliance initiatives in the pharma, biotech and device sectors to attend this year's Pharma Congress. This year we have transformed the event into a new type of learning experience and interactive best practices exchange. Click here for your formal invitation.
|
|
FEATURING
|
- Identification and analysis of the top five pharmaceutical compliance issues in 2006. Harvard Law Professor Arthur Miller will facilitate the discussion of these key compliance challenges. Discussion and problem solving around these key issues will be woven throughout the conference.
- Interactive idea exchange. In the plenary sessions each attendee will have a Meridia Audience response device with which he or she will be able to vote on questions put by the faculty. The attendee responses will be immediately projected on the session screens.
- Participation in a sophisticated hypothetical exercise that will continue throughout the conference. The hypothetical will include a variety of factual scenarios relating to issues raised by the top five pharmaceutical compliance issues in 2006. Attendees will be challenged to apply their new knowledge to specific hypothetical fact circumstances. Results of the hypothetical will be shared on the last day of the conference.
- Track sessions which will be longer and will permit substantive learning and knowledge exchange, as well as the application of these bodies of knowledge to the changing Pharma Congress hypothetical.
- Two unique networking reception opportunities. The Monday evening opening networking reception will feature an opportunity to meet a number of key Federal and state regulators and Capital Hill specializing in pharmaceutical policy. The Pharma Congress Tuesday networking reception will feature the exchange and presentation of company Codes of Conduct at poster boards throughout the Pharma Congress Exhibit Hall.
- An extraordinary series of keynote speakers.
|
|
PCF PHARMA CONGRESS PLANNING COMMITTEE
|
Arjun Rajaratnam
Vice President and Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP (Co chair)
John Alivernini, Esq.
Vice President and Chief, Compliance Officer, Wyeth Pharmaceuticals
John T. Bentivoglio, Esq.
Partner, King & Spalding LLP
David B. Chandler, Ph.D., DABT
Manager, Compliance, 3M Pharmaceuticals
Anthony L. Farino
Partner, US Leader Life Sciences, Advisory Practice, PricewaterhouseCoopers LLP
Peter N. Grant, JD, Ph.D.
President, Health Care Conference Administrators, LLC
Keith M. Korenchuk, JD, MPH
Partner, McGuire Woods
Steve Mohr, Esq.
Deputy Compliance Officer, AstraZeneca
Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company
Catherine Sazdanoff
Divisional Vice President, Ethics and Compliance, Abbott Laboratories
Michael Shaw
Deputy Compliance Officer, Novartis Pharmaceuticals Corporation
Paul J. Silver
National Leader, Health Sciences, Investigative and Dispute Services, Ernst & Young LLP
Jonathan K. Sprole
Chief Compliance Officer, Bristol-Myers Squibb Company
Sheryl Vacca, CHC
West Coast Life Science and Health Care Regulatory, Practice Leader, Deloitte & Touche LLP
|
|
|
|
KEYNOTE SPEAKERS
|
Sheldon T. Bradshaw, Esq.
Chief Counsel, Food and Drug Division, Washington, DC
|
|
Randy Cohen
Author, "The Ethicist", The New York Times Magazine, New York, NY
|
|
Alice Fisher, Esq.
Assistant Attorney General, Criminal Division, United States Department of Justice, Washington, DC
|
|
Scott Gottlieb, MD
Deputy Commissioner for Medical and Scientific Affairs, Office of the Commissioner, Food and Drug Administration, Washington, DC
|
|
Senator Chuck Grassley (R/IA)
United States Senate, Ranking Member, Chairman of the Senate Finance Committee, Washington, DC
|
|
Daniel R. Levinson
Inspector General, Department of Health and Human Services, Washington, DC
|
|
Arthur Miller, Esq.
Bruce Bromley Professor of Law, Harvard Law School, Cambridge, MA
|
|
James Moorman
President and Chief Executive Officer, Taxpayers Against Fraud, Washington, DC
|
|
Thomas Scully
Senior Counsel, Alston & Bird, Senior Adviser, Welsh, Carson, Anderson and Stowe, and Former Administrator, Centers for Medicare and Medicaid Services, Department of Health & Human Services, Washington, DC
|
|
James Sheehan, Esq.
Associate United States Attorney, U.S. Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA
|
|
Susan Winkler, Esq.
Assistant United States Attorney, Deputy Health Care Fraud Chief, United States Attorney's Office, District of Massachusetts, Boston, MA
|
|
Alan Yuspeh, JD, MBA
Senior Vice President, Ethics, Compliance and Corporate Responsibility, HCA Healthcare Corporation and Former Coordinator, Defense Industry Initiative on Business Ethics and Conduct, Nashville, TN
|
|
Babette S. Edgar, Pharm.D., MBA
Director, Division of Finance and Operations, Medicare Drug Benefit Group, Centers for Medicare & Medicaid Services, Washington, DC
|
|
|
|
CONGRESS CO CHAIRS
|
John T. Bentivoglio, Esq.
Partner, King & Spalding, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC
|
|
Keith M. Korenchuk, JD, MPH
Partner, McGuire Woods, Charlotte, NC
|
|
Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC
|
|
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
|
|
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
|
|
|
|
|
|
SPONSORED BY:
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
COSPONSORED BY:
|
|
ASSOCIATIONS
|
|
|
PUBLICATIONS
|
|
|
|
